查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1492232

人工軟骨植入市場：按類型、最終用戶分類 - 2024-2030 年全球預測

Artificial Cartilage Implant Market by Type (Lower Extremity Joints, Upper Extremity Joints, Vertebral Joints), End-User (Ambulatory Surgery Centers, Clinics, Hospitals) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年人工軟骨植入市場規模為11822萬美元，2024年達13579萬美元，預計2030年將達32169萬美元，複合年成長率為15.37%。

人工軟骨植入是一種旨在模仿天然軟骨功能的尖端醫療設備。此植入主要用於整形外科手術，治療因骨關節炎、創傷和老齡化相關磨損等原因造成軟骨損傷的患者。這項創新具有巨大的潛力，可以改善數百萬關節疼痛和劣化患者的生活品質。與傳統的軟骨損傷治療方法相比，人工軟骨植入具有一系列優勢，為更有效、持久和侵入性較小的解決方案鋪平了道路。由於人口老化、肌肉骨骼疾病的盛行率增加、材料科學的技術進步以及整形外科手術成功率的提高，全球人工軟骨植入市場正在經歷顯著成長。然而，人工軟骨植入市場面臨手術成本上升以及對植入壽命和術後併發症的擔憂等挑戰。全球醫療保健基礎設施投資的增加正在增加人工軟骨植入市場的擴張潛力。

主要市場統計
基準年[2023] 11822萬美元
預測年份 [2024] 1.3579億美元
預測年份 [2030] 3.2169億美元
複合年成長率（%） 15.37%

區域洞察

美洲人工軟骨植入市場的活性化是強大的醫療基礎設施和高研發活動。美國的技術進步和創新正在推動美國地區人工軟骨植入市場的成長。骨關節炎和運動相關損傷的日益普及以及人口老化正在推動美洲對人工軟骨植入的需求。由於對先進治療方法的認知不斷提高和醫療保健支出不斷增加，亞太地區的人工軟骨植入市場呈現顯著成長。中國、日本和韓國正在投資醫療基礎設施並增加整形外科手術數量。人口老化的加劇和關節相關疾病盛行率的增加正在推動該地區的市場成長。歐洲、中東和非洲地區為人工軟骨植入提供了多樣化的市場環境。歐洲強調醫療質量，醫療費用較高。既定的醫療保健政策和研發資金也支持人工軟骨植入的採用。中東和非洲的人工軟骨植入市場正在興起，海灣國家對醫療基礎設施的投資正在取得進展，對先進醫療技術的興趣也在增加。

FPNV定位矩陣

FPNV 定位矩陣對於評估供應商在人工軟骨植入市場的定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可對人工軟骨植入市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭力的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在人工軟骨植入市場中的地位進行全面評估，使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 膝關節和腕掌骨骨關節炎的盛行率增加
      • 人們對人工軟骨植入的認知不斷增強
      • 不斷上漲的醫療費用和先進的醫療設施
    • 抑制因素
      • 人工軟骨和置換手術的高成本
    • 機會
      • 植入材料和手術技術的技術進步
      • 開發用於生產人工軟骨植入的智慧和3D列印技術
    • 任務
      • 與人工軟骨植入相關的併發症
  • 市場區隔分析
    • 類型：由於骨關節炎盛行率高，對下肢關節的需求增加，人工軟骨植入
    • 最終用戶：大型患者照護機構對醫院人工軟骨植入的需求不斷增加
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章人工軟骨植入市場：依類型

  • 下肢關節
  • 上肢關節
  • 脊椎骨關節

第7章人工軟骨植入市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第8章北美和南美人工軟骨植入市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區人工軟骨植入市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東、非洲人工軟骨植入市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 瑞士大學資助 1,300 萬美元開始膝關節假體試驗
    • Sparta 加強 Olumi植入的專利保護
    • CartiHeal 宣佈在美國推出第一個 Agili-C商業性植入
  • 戰略分析和建議

第12章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-351BAD503B27

[185 Pages Report] The Artificial Cartilage Implant Market size was estimated at USD 118.22 million in 2023 and expected to reach USD 135.79 million in 2024, at a CAGR 15.37% to reach USD 321.69 million by 2030.

An Artificial Cartilage Implant is a cutting-edge medical device designed to mimic the function of natural cartilage. This implant is utilized primarily in orthopedic surgeries to treat patients suffering from cartilage damage, resulting from conditions such as osteoarthritis, trauma, or wear and tear due to aging. The innovation holds significant potential to enhance the quality of life for millions affected by joint pain and deterioration. Artificial cartilage implants present a series of advantages over traditional treatment methods for cartilage damage, paving the way for more effective, long-lasting, and less intrusive solutions. The global market for artificial cartilage implants is witnessing substantial growth, driven by an aging population, rising prevalence of musculoskeletal disorders, and technological advancements in material science and increasing success rates of orthopedic surgeries. However, the artificial cartilage implant market faces challenges, including high costs of surgery, and concerns over implant longevity and post-surgery complications. The increasing investment in healthcare infrastructure globally augments the potential for artificial cartilage implants market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 118.22 million
Estimated Year [2024] USD 135.79 million
Forecast Year [2030] USD 321.69 million
CAGR (%) 15.37%

Regional Insights

The artificial cartilage implant market in the Americas is characterized by robust healthcare infrastructure and increased focus on research and development activities. Technological advancements and innovation in the United States are driving the growth of the artificial cartilage implant market in the American region. The rising prevalence of osteoarthritis and sports-related injuries, combined with an aging population, has boosted the demand for artificial cartilage implants in the Americas. The Asia-Pacific region showcases significant growth in the artificial cartilage implant market owing to increasing awareness of advanced treatment methods and rising healthcare expenditures. China, Japan, and South Korea are investing in healthcare infrastructure and a growing number of orthopedic procedures. The increase in the aging population and a higher incidence of joint-related disorders drive the market growth in this region. The EMEA region shows a diverse market landscape for artificial cartilage implants. Europe has a strong emphasis on healthcare quality and high healthcare expenditure. Well-established healthcare policies and funding for research and development also support the adoption of artificial cartilage implants. The artificial cartilage implant market is emerging in the Middle East and Africa, with the Gulf countries investing in healthcare infrastructure and showing increasing interest in advanced medical technologies.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Artificial Cartilage Implant Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing prevalence of osteoarthritis of knee joint and carpometacarpal
      • Rising awareness regarding artificial cartilage implants
      • Growing healthcare expenditure and advanced healthcare facilities
    • Market Restraints
      • High cost associated with the artificial cartilage and replacement surgeries
    • Market Opportunities
      • Technological advancements in implant materials and surgical techniques
      • Development of smart and 3D printing technologies for artificial cartilage implants manufacturing
    • Market Challenges
      • Complications factors associated with artificial cartilage implants
  • Market Segmentation Analysis
    • Type: Increasing demand for lower extremity joints artificial cartilage implant owing to the high prevalence of osteoarthritis
    • End-User: Rising demand for artificial cartilage implants in hospitals for extensive patient care facilities
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Artificial Cartilage Implant Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Artificial Cartilage Implant Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Swiss university launches artificial knee trial backed by USD 13 million

The University of Basel is set to initiate a groundbreaking series of clinical trials across Europe, backed with a substantial USD 13.1 million in government funding, to explore the efficacy of a pioneering surgical procedure involving the grafting of Nasal Chondrocyte Tissue-Engineered Cartilage (NTEC) into knee joints affected by osteoarthritis (OA). This innovative approach, exclusively targeting patellofemoral OA and not suitable for cases of rheumatoid arthritis, aims to negate the immediate need for total knee replacement by rejuvenating the damaged cartilage. [Published On: 2023-11-15]

Sparta strengthens patent protection for Ormi implant

Sparta Biomedical has achieved a significant milestone with the acquisition of two new patents from the US Patent and Trademark Office for its cutting-edge Ormi implant, a promising solution for osteoarthritis treatment. This state-of-the-art implant harnesses the innovative synthetic cartilage, Galene, supported by a porous titanium base, designed to repair the damaged knee and restore its full functionality. The unique porous titanium structure encourages bone integration, ensuring a durable joint fixation. [Published On: 2023-08-25]

CartiHeal Announces First Commercial Implantation of Agili-C in the US

CartiHeal Ltd., a developer of innovative implants designed for the treatment of cartilage and osteochondral flaws in arthritic and non-arthritic knee joints, announces the US's first commercial implantation of its revolutionary Agili-C product. The Agili-C implant, distinguished by its unique bi-phasic design, promotes bone remodeling and cartilage regeneration. [Published On: 2023-07-26]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Artificial Cartilage Implant Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Artificial Cartilage Implant Market, highlighting leading vendors and their innovative profiles. These include Anika Therapeutics, Inc., BioPoly, LLC, CartiHeal, Inc. by Smith & Nephew PLC, CytoSeek Limited, Medtronic PLC, Narang Medical Limited, NUsurface, Orthox Ltd., Sartorius CellGenix GmbH, Sparta Biomedical Inc., Stryker Corporation, Uteshiya Medicare, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Artificial Cartilage Implant Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Lower Extremity Joints
    • Upper Extremity Joints
    • Vertebral Joints
  • End-User
    • Ambulatory Surgery Centers
    • Clinics
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of osteoarthritis of knee joint and carpometacarpal
      • 5.1.1.2. Rising awareness regarding artificial cartilage implants
      • 5.1.1.3. Growing healthcare expenditure and advanced healthcare facilities
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the artificial cartilage and replacement surgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in implant materials and surgical techniques
      • 5.1.3.2. Development of smart and 3D printing technologies for artificial cartilage implants manufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. Complications factors associated with artificial cartilage implants
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing demand for lower extremity joints artificial cartilage implant owing to the high prevalence of osteoarthritis
    • 5.2.2. End-User: Rising demand for artificial cartilage implants in hospitals for extensive patient care facilities
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Artificial Cartilage Implant Market, by Type

  • 6.1. Introduction
  • 6.2. Lower Extremity Joints
  • 6.3. Upper Extremity Joints
  • 6.4. Vertebral Joints

7. Artificial Cartilage Implant Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgery Centers
  • 7.3. Clinics
  • 7.4. Hospitals

8. Americas Artificial Cartilage Implant Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Artificial Cartilage Implant Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Artificial Cartilage Implant Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Swiss university launches artificial knee trial backed by USD 13 million
    • 11.3.2. Sparta strengthens patent protection for Ormi implant
    • 11.3.3. CartiHeal Announces First Commercial Implantation of Agili-C in the US
  • 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL CARTILAGE IMPLANT MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ARTIFICIAL CARTILAGE IMPLANT MARKET DYNAMICS
  • FIGURE 7. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ARTIFICIAL CARTILAGE IMPLANT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. ARTIFICIAL CARTILAGE IMPLANT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL CARTILAGE IMPLANT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY LOWER EXTREMITY JOINTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY LOWER EXTREMITY JOINTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY UPPER EXTREMITY JOINTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY UPPER EXTREMITY JOINTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY VERTEBRAL JOINTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY VERTEBRAL JOINTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 24. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 25. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 26. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 27. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 28. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 30. ARGENTINA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 32. ARGENTINA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 33. BRAZIL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 34. BRAZIL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 35. BRAZIL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 36. BRAZIL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 37. CANADA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. CANADA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. CANADA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 40. CANADA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 41. MEXICO ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 42. MEXICO ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 43. MEXICO ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 44. MEXICO ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 48. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 50. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. AUSTRALIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. AUSTRALIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. CHINA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. CHINA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. CHINA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 64. CHINA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 65. INDIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. INDIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. INDIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 68. INDIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 69. INDONESIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. INDONESIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. INDONESIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. INDONESIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. JAPAN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. JAPAN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. JAPAN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 76. JAPAN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 77. MALAYSIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. MALAYSIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. MALAYSIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 80. MALAYSIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 82. PHILIPPINES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 84. PHILIPPINES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 85. SINGAPORE ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. SINGAPORE ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. SINGAPORE ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 88. SINGAPORE ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. SOUTH KOREA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. SOUTH KOREA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. TAIWAN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 94. TAIWAN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 95. TAIWAN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. TAIWAN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. THAILAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. THAILAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. THAILAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 100. THAILAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 101. VIETNAM ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. VIETNAM ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. VIETNAM ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 104. VIETNAM ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 111. DENMARK ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. DENMARK ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. DENMARK ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 114. DENMARK ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 115. EGYPT ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. EGYPT ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. EGYPT ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. EGYPT ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. FINLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. FINLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. FINLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 122. FINLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 123. FRANCE ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. FRANCE ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. FRANCE ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 126. FRANCE ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 127. GERMANY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. GERMANY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. GERMANY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. GERMANY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. ISRAEL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. ISRAEL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. ISRAEL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. ISRAEL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. ITALY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. ITALY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. ITALY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 138. ITALY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. NETHERLANDS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 142. NETHERLANDS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 143. NIGERIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. NIGERIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. NIGERIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 146. NIGERIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 147. NORWAY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. NORWAY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. NORWAY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 150. NORWAY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 151. POLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. POLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. POLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. POLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. QATAR ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. QATAR ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. QATAR ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 158. QATAR ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 159. RUSSIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. RUSSIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. RUSSIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 162. RUSSIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. SAUDI ARABIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. SAUDI ARABIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. SOUTH AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. SPAIN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. SPAIN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. SPAIN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. SPAIN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. SWEDEN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. SWEDEN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. SWEDEN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 178. SWEDEN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. SWITZERLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 182. SWITZERLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 183. TURKEY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. TURKEY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. TURKEY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. TURKEY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. UNITED KINGDOM ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 194. UNITED KINGDOM ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 195. ARTIFICIAL CARTILAGE IMPLANT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 196. ARTIFICIAL CARTILAGE IMPLANT MARKET, FPNV POSITIONING MATRIX, 2023